Publications in collaboration with researchers from Karolinska Institute (20)

2024

  1. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

    Pediatric Allergy and Immunology, Vol. 35, Núm. 4

2020

  1. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 8, pp. 2592-2599.e3

2017

  1. Addressing unmet needs in understanding asthma mechanisms

    European Respiratory Journal, Vol. 49, Núm. 5

  2. Asthma research in Europe: A transformative agenda for innovation and competitiveness

    European Respiratory Journal, Vol. 49, Núm. 5

2016

  1. Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument

    Clinical and Experimental Allergy

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270

  2. Classification and pharmacological treatment of preschool wheezing: Changes since 2008

    European Respiratory Journal

2013

  1. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three

    Clinical and Experimental Allergy, Vol. 43, Núm. 1, pp. 73-84

2012

  1. The challenges of replicating the methodology between Phases I and III of the ISAAC programme

    International Journal of Tuberculosis and Lung Disease, Vol. 16, Núm. 5, pp. 687-693

2011

  1. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International study of asthma and allergies in childhood phase three

    American Journal of Respiratory and Critical Care Medicine, Vol. 183, Núm. 2, pp. 171-178

  2. Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three

    Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325

2010

  1. International variations in bronchial responsiveness in children: Findings from ISAAC phase two

    Pediatric Pulmonology, Vol. 45, Núm. 8, pp. 796-806

  2. The impact of the method of consent on response rates in the ISAAC time trends study

    International Journal of Tuberculosis and Lung Disease, Vol. 14, Núm. 8, pp. 1059-1065

  3. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One

    Respiratory Research, Vol. 11

2009

  1. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 64, Núm. 1, pp. 123-148

  2. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

    Thorax, Vol. 64, Núm. 6, pp. 476-483

  3. Translation of questions: The International Study of Asthma and Allergies in Childhood (ISAAC) experience

    International Journal of Tuberculosis and Lung Disease, Vol. 13, Núm. 9, pp. 1174-1182

2008

  1. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme

    The Lancet, Vol. 372, Núm. 9643, pp. 1039-1048

2007

  1. Atopic sensitization and the international variation of asthma symptom prevalence in children

    American Journal of Respiratory and Critical Care Medicine, Vol. 176, Núm. 6, pp. 565-574

2004

  1. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): Rationale and methods

    European Respiratory Journal, Vol. 24, Núm. 3, pp. 406-412